← Leaderboards
Elvin Wagenblast
Icahn School Of Medicine At Mount Sinai
$1,967,421
Attributed
$2,198,648
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,198,648 · 3
By mechanism
R01$1,736,194 · 2
R21$462,454 · 1
Top collaborators
- Sai Ma1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Carmen Argmann$789,913
- Alexandra Munch$141,406
- Saghi Ghaffari$11,733,780
- Maria Sosa$2,004,076
- Anastasia Efthymiou$131,700
Others in their field
Other Rising Stars on “Leukemia”
- Michael E. Roth · Public Health Institute$8,201,777
- Alexander Federation · Talus Bioscience, Inc.$4,406,023
- Erin Marcotte · University Of Minnesota$4,360,951
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Martin Pule · University College London$3,627,871
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$3,571,151
Research focus
LeukemiaFetalPrenatalTranscription FactorPredispositionSamplingHematopoietic Stem CellsMalignant NeoplasmsTherapeutic InterventionFetal LiverMolecularCellsMutationGenetic TranscriptionAcute Myelocytic LeukemiaFetal DevelopmentBone MarrowChildPathway InteractionsMediatingKnock-OutIn Vivo ModelCandidate Disease GeneChildhood
Grant awards (5)
Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia$462,454
R21 · FY2025 · CA
Overcoming Therapy Resistance in Fusion Oncoprotein Driven Pediatric Leukemia$441,178
R01 · FY2025 · CA · contact PI
Intrinsic and Extrinsic Factors Contributing to Trisomy 21 Preleukemia$426,919
R01 · FY2025 · CA · contact PI
Overcoming Therapy Resistance in Fusion Oncoprotein Driven Pediatric Leukemia$441,178
R01 · FY2024 · CA · contact PI
Intrinsic and Extrinsic Factors Contributing to Trisomy 21 Preleukemia$426,919
R01 · FY2024 · CA · contact PI